To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019
World Health Organization, Geneva, Switzerland.
Skin and GU Medicine Clinic, Harare, Zimbabwe.
University of Alabama at Birmingham, Birmingham, AL, USA.
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Show others and affiliations
2020 (English)In: Vaccine, ISSN 0264-410X, E-ISSN 1873-2518, Vol. 38, no 28, p. 4362-4373Article in journal (Refereed) Published
Abstract [en]

Renewed interest in developing vaccines against Neisseria gonorrhoeae has been sparked by the increasing threat of gonococcal antimicrobial resistance (AMR) and growing optimism that gonococcal vaccines are biologically feasible. Evidence suggests serogroup B Neisseria meningitidis vaccines might provide some cross-protection against N. gonorrhoeae, and new gonococcal vaccine candidates based on several approaches are currently in preclinical development. To further stimulate investment and accelerate development of gonococcal vaccines, greater understanding is needed regarding the overall value that gonococcal vaccines might have in addressing public health and societal goals in low-, middle-, and high-income country contexts and how future gonococcal vaccines might be accepted and used, if available. In January 2019, the World Health Organization (WHO) convened a multidisciplinary international group of experts to lay the groundwork for understanding the potential health, economic, and societal value of gonococcal vaccines and their likely acceptance and use, and for developing gonococcal vaccine preferred product characteristics (PPCs). WHO PPCs describe preferences for vaccine attributes that would help optimize vaccine value and use in meeting the global public health need. This paper describes the main discussion points and conclusions from the January 2019 meeting of experts. Participants emphasized the need for vaccines to control N. gonorrhoeae infections with the ultimate goals of preventing adverse sexual and reproductive health outcomes (e.g., infertility) and reducing the impact of gonococcal AMR. Meeting participants also discussed important PPC considerations (e.g., vaccine indications, target populations, and potential immunization strategies) and highlighted crucial research and data needs for guiding the value assessment and PPCs for gonococcal vaccines and advancing gonococcal vaccine development.

Place, publisher, year, edition, pages
Elsevier, 2020. Vol. 38, no 28, p. 4362-4373
Keywords [en]
Gonococcal vaccines, Gonorrhea, Neisseria gonorrhoeae, Sexually transmitted infections, Vaccines
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:oru:diva-81728DOI: 10.1016/j.vaccine.2020.02.073ISI: 000537316500002PubMedID: 32359875Scopus ID: 2-s2.0-85083888638OAI: oai:DiVA.org:oru-81728DiVA, id: diva2:1429919
Note

Funding Agencies:

Global Challenges Research Fund (GCRF) Networks in Vaccines Research and Development  

Medical Research Council UK (MRC)

Biotechnology and Biological Sciences Research Council (BBSRC) BVNCP-03

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction  

United States Department of Health & Human Services

National Institutes of Health (NIH) - USA

NIH National Institute of Allergy & Infectious Diseases (NIAID) U01AI139547

Available from: 2020-05-13 Created: 2020-05-13 Last updated: 2020-12-01Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Unemo, Magnus

Search in DiVA

By author/editor
Unemo, Magnus
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Vaccine
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 30 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf